Japan Approves Test of iPS Cells for Treating Spinal Injuries

February 18, 2019

(Reuters) – Japanese scientists will test the use of human-induced pluripotent stem cells (iPS) to treat spinal cord injuries, a health ministry panel that approved the research project said on Monday.  The research team from Tokyo’s Keio University planned to inject about two million iPS cells into the damaged areas of an individual patient and review the results over the course of a year, according to the plan approved by the health ministry.